Skip to main content

US ClosedU.S. Closed

ANL: Adlai Nortye Ltd. Stock Analysis | finqOS

Healthcare · Biotechnology

Adlai Nortye Ltd. (ANL) is a clinical-stage biotechnology firm dedicated to the research and development of innovative pharmaceutical products.

52W Range

79thpctl

Volume

0.78×avg

Market Cap

733.57MUSD

P/E Ratio

-7.1TTM

Div Yield

-ann

Loading chart data...

Current StateState loading

Adlai Nortye Ltd.

ANLNASDAQ Global Market·USD·Closed

Adlai Nortye Ltd.

ANLNASDAQ·USD·Closed

$13.82

−3.49%

$13.82

−$0.50 (3.49%)

52W Range

79thpctl

Volume

0.78×avg

Mkt Cap

733.57MUSD

P/E

-7.1TTM

Div Yield

–ann